T 0816/22 (C1-esterase inhibitor for AMR/TAKEDA) of 19.11.2024
- European Case Law Identifier
- ECLI:EP:BA:2024:T081622.20241119
- Date of decision
- 19 November 2024
- Case number
- T 0816/22
- Petition for review of
- -
- Application number
- 14809567.2
- Language of proceedings
- English
- Distribution
- No distribution (D)
- Download
- Decision in English
- OJ versions
- No OJ links found
- Other decisions for this case
- -
- Abstracts for this decision
- Abstract on Article 083 EPC
- Application title
- Methods of treating antibody-mediated rejection in organ transplant patients with C1-esterase inhibitor
- Applicant name
- Takeda Pharmaceutical Company Limited
- Opponent name
- CSL Innovation Pty Ltd
- Board
- 3.3.04
- Headnote
- -
- Relevant legal provisions
- European Patent Convention Art 83
- Keywords
- Sufficiency of disclosure - reproducibility (no)
- Catchword
- -
- Cited cases
- -
- Citing cases
- -
Order
For these reasons it is decided that:
1. The decision under appeal is set aside.
2. The patent is revoked.